Roivant Sciences Ltd at Piper Sandler Healthcare Conference Transcript
I think we can go ahead and get started with our next session. So my name is Ally Bratzel. I'm 1 of the senior analysts here at Piper Sandler, and it's my pleasure to introduce Matt Gline, CEO of Roivant.
Thank you for having me.
Questions & Answers
Yes. So thanks for joining us. And also just for the audience, if anyone has any questions, feel free to either just raise your hand or shoot me an e-mail, and I'll be sure to ask it. But yes, I have a bunch of questions, so I'm going to go ahead and get us started off.
So Matt, maybe starting off high level, it's fair to say that the world we're living in today looks a lot different than even than it did this time last year across Roivant. The Telavant transaction, proof-of-concept data for 1402,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
